ACUDERM, INC.
FT LAUDERDALE, FLORIDA

Founded in Fort Lauderdale, Florida, in 1983, Acuderm, Inc. has dedicated itself to providing top-notch products and services for dermatological procedures. With a mission centered around quality and value, the company holds eight US patents and one international patent, marking its role as an innovator in the field. Acuderm's commitment to excellence is reflected in its adherence to a robust set of regulations and standards. In the United States, the company has received FDA certification and adheres to UL2601 guidelines. On the global stage, it boasts ISO 13485 certification, a CE mark for Europe, and CMDCAS compliance in Canada. These certifications underscore Acuderm's pledge to maintaining superior quality assurance practices. Guided by key leaders such as President Charles R Yeh, Secretary E Nakamura, and Director J Zalla, Acuderm continues to grow through new product developments endorsed by their Medical Advisors and Board of Directors. In an effort to support healthcare providers, the company has recently expanded its services, offering assistance in setting up new clinics efficiently and economically without sacrificing quality. Headquartered at 6555 Powerline Road, Suite 114 in Fort Lauderdale, Acuderm can be reached through various phone lines for more information or inquiries. They remain compliant with a range of regulatory standards including FDA 21CFR Part 820, ISO 13485:2003, CMDCAS regulations, CE MDD Annex V, and UL 2601. For further details on their offerings, check out their website at acuderm.com. Incorporated in Florida under the Filed Number G10787, with significant updates reported as of February 21, 2024, Acuderm continues to set benchmarks for quality and innovation in the dermatologic sector.